| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72888-108-00 | 72888-108 | HUMAN PRESCRIPTION DRUG | Carbidopa-levodopa | carbidopa and levodopa | TABLET | ORAL | 20210729 | N/A | ANDA | ANDA216505 | Advagen Pharma Ltd., | CARBIDOPA; LEVODOPA | 25 mg/1; 250 mg/1 | 1000 TABLET in 1 BOTTLE (72888-108-00) |
| 72888-108-01 | 72888-108 | HUMAN PRESCRIPTION DRUG | Carbidopa-levodopa | carbidopa and levodopa | TABLET | ORAL | 20210729 | N/A | ANDA | ANDA216505 | Advagen Pharma Ltd., | CARBIDOPA; LEVODOPA | 25 mg/1; 250 mg/1 | 100 TABLET in 1 BOTTLE (72888-108-01) |
| 72888-108-05 | 72888-108 | HUMAN PRESCRIPTION DRUG | Carbidopa-levodopa | carbidopa and levodopa | TABLET | ORAL | 20210729 | N/A | ANDA | ANDA216505 | Advagen Pharma Ltd., | CARBIDOPA; LEVODOPA | 25 mg/1; 250 mg/1 | 500 TABLET in 1 BOTTLE (72888-108-05) |
| 72888-108-30 | 72888-108 | HUMAN PRESCRIPTION DRUG | Carbidopa-levodopa | carbidopa and levodopa | TABLET | ORAL | 20210729 | N/A | ANDA | ANDA216505 | Advagen Pharma Ltd., | CARBIDOPA; LEVODOPA | 25 mg/1; 250 mg/1 | 30 TABLET in 1 BOTTLE (72888-108-30) |